Outset Medical, Inc. Operating Expenses
Outset Medical, Inc. (OM) reported Operating Expenses of $28.96 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- Outset Medical, Inc. operating expenses for the quarter ending 2026-06-30 was $28.96M, a 0.79% increase year-over-year.
- Outset Medical, Inc. operating expenses for the quarter ending 2026-03-31 was $29.01M, a 5.64% increase year-over-year.
- Outset Medical, Inc. operating expenses for the quarter ending 2025-12-31 was $29.86M, a 8.42% decline year-over-year.
- Outset Medical, Inc. operating expenses for the quarter ending 2025-09-30 was $27.40M, a 18.59% decline year-over-year.
- Outset Medical, Inc. operating expenses for fiscal 2025 was $113.46M, a 25.33% decline from fiscal 2024.
- Outset Medical, Inc. operating expenses for fiscal 2024 was $151.94M, a 23.56% decline from fiscal 2023.
- Outset Medical, Inc. operating expenses for fiscal 2023 was $198.77M, a 11.14% increase from fiscal 2022.
- Outset Medical, Inc. operating expenses for fiscal 2022 was $178.85M, a 29.48% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.96M 10-Q · filed 2026-08-06 | $57.97M 10-Q · filed 2026-08-06 | $87.83M derived: sum of 3 quarters · filed 2026-08-06 | $115.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $29.01M 10-Q · filed 2026-05-07 | $58.87M derived: sum of 2 quarters · filed 2026-05-07 | $86.28M derived: sum of 3 quarters · filed 2026-05-07 | $115.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $29.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $57.26M derived: sum of 2 quarters · filed 2026-02-13 | $86.00M derived: sum of 3 quarters · filed 2026-08-06 | $113.46M 10-K · filed 2026-02-13 |
| 2025-09-30 | $27.40M 10-Q · filed 2025-11-10 | $56.13M derived: sum of 2 quarters · filed 2026-08-06 | $83.60M 10-Q · filed 2025-11-10 | $116.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $28.73M 10-Q · filed 2026-08-06 | $56.20M 10-Q · filed 2026-08-06 | $88.80M derived: sum of 3 quarters · filed 2026-08-06 | $122.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $27.46M 10-Q · filed 2026-05-07 | $60.07M derived: sum of 2 quarters · filed 2026-05-07 | $93.73M derived: sum of 3 quarters · filed 2026-05-07 | $134.28M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $32.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $66.27M derived: sum of 2 quarters · filed 2026-02-13 | $106.81M derived: sum of 3 quarters · filed 2026-02-13 | $151.94M 10-K · filed 2026-02-13 |
| 2024-09-30 | $33.66M 10-Q · filed 2025-11-10 | $74.20M derived: sum of 2 quarters · filed 2025-11-10 | $119.33M 10-Q · filed 2025-11-10 | $164.40M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $40.55M 10-Q · filed 2025-08-07 | $85.67M 10-Q · filed 2025-08-07 | $130.74M derived: sum of 3 quarters · filed 2026-02-13 | $183.35M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $45.13M 10-Q · filed 2025-05-08 | $90.19M derived: sum of 2 quarters · filed 2026-02-13 | $142.80M derived: sum of 3 quarters · filed 2026-02-13 | $193.98M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $45.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $97.68M derived: sum of 2 quarters · filed 2026-02-13 | $148.86M derived: sum of 3 quarters · filed 2026-02-13 | $198.77M 10-K · filed 2026-02-13 |
| 2023-09-30 | $52.61M 10-Q · filed 2024-11-07 | $103.79M derived: sum of 2 quarters · filed 2024-11-07 | $153.71M 10-Q · filed 2024-11-07 | $198.80M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $51.18M 10-Q · filed 2024-08-08 | $101.09M 10-Q · filed 2024-08-08 | $146.19M derived: sum of 3 quarters · filed 2025-02-28 | $191.53M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $49.91M 10-Q · filed 2024-05-09 | $95.01M derived: sum of 2 quarters · filed 2025-02-28 | $140.34M derived: sum of 3 quarters · filed 2025-02-28 | $187.85M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $45.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $90.43M derived: sum of 2 quarters · filed 2025-02-28 | $137.94M derived: sum of 3 quarters · filed 2025-02-28 | $178.85M 10-K · filed 2025-02-28 |
| 2022-09-30 | $45.34M 10-Q · filed 2023-11-08 | $92.84M derived: sum of 2 quarters · filed 2023-11-08 | $133.75M 10-Q · filed 2023-11-08 | $177.88M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $47.50M 10-Q · filed 2023-08-03 | $88.42M 10-Q · filed 2023-08-03 | $132.54M derived: sum of 3 quarters · filed 2024-02-21 | $165.62M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $40.92M 10-Q · filed 2023-05-04 | $85.04M derived: sum of 2 quarters · filed 2024-02-21 | $118.12M derived: sum of 3 quarters · filed 2024-02-21 | $149.08M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $44.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $77.20M derived: sum of 2 quarters · filed 2024-02-21 | $108.16M derived: sum of 3 quarters · filed 2024-02-21 | $138.13M 10-K · filed 2024-02-21 |
| 2021-09-30 | $33.08M 10-Q · filed 2022-11-09 | $64.04M derived: sum of 2 quarters · filed 2022-11-09 | $94.01M 10-Q · filed 2022-11-09 | $126.04M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $30.96M 10-Q · filed 2022-08-02 | $60.92M 10-Q · filed 2022-08-02 | $92.95M derived: sum of 3 quarters · filed 2023-02-13 | $128.56M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $29.96M 10-Q · filed 2022-05-05 | $62.00M derived: sum of 2 quarters · filed 2023-02-13 | $97.60M derived: sum of 3 quarters · filed 2023-02-13 | $117.75M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $32.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $67.64M derived: sum of 2 quarters · filed 2023-02-13 | $87.78M derived: sum of 3 quarters · filed 2023-02-13 | $104.43M 10-K · filed 2023-02-13 |
| 2020-09-30 | $35.61M 10-Q · filed 2021-11-04 | $55.75M derived: sum of 2 quarters · filed 2021-11-04 | $72.40M 10-Q · filed 2021-11-04 | $88.19M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $20.14M 10-Q · filed 2021-08-06 | $36.79M 10-Q · filed 2021-08-06 | $52.58M derived: sum of 3 quarters · filed 2022-02-23 | $65.74M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $16.65M 10-Q · filed 2021-05-06 | $32.44M derived: sum of 2 quarters · filed 2022-02-23 | $45.59M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2019-12-31 | $15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $28.95M derived: sum of 2 quarters · filed 2022-02-23 | $52.51M 10-K · filed 2022-02-23 | |
| 2019-09-30 | $13.16M 10-Q · filed 2020-11-12 | $36.72M 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | $40.45M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |